ChartMill assigns a Buy % Consensus number of 83% to RNTX. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-22 | HC Wainwright & Co. | Initiate | Buy |
| 2025-08-19 | Brookline Capital | Downgrade | Buy -> Hold |
8 analysts have analysed RNTX and the average price target is 8.16 USD. This implies a price increase of 500% is expected in the next year compared to the current price of 1.36.
The consensus rating for REIN THERAPEUTICS INC (RNTX) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.